| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
4
4
5
5
3
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
A+
(Buy)
|
Fund Performance
The fund's Value Line Growth Persistence rank, which awards funds that consistently outperform their broad universes, is 3 for one year, 3 for five years, and 2 for 10 years. Scores are on a 1 to 5 scale, with 1 being the best and 5 the worst.
Value Line 2013-03-12
Hypothetical Growth of $10,000
Updated 04.30.2013
Trailing Total Returns
Updated 04.30.2013
| Total Return % | + / - MSCI World NR USD | + / - DJ US Health Care TR USD | % Rank | |
|---|---|---|---|---|
| Year-to-date | 18.16 | 7.04 | -1.69 | 73 |
| 1-Month | 3.23 | 0.08 | -0.06 | 63 |
| 3-Month | 10.95 | 5.21 | -0.49 | 62 |
| 6-Month | 18.89 | 4.23 | -1.65 | 77 |
| 1-Year | 26.62 | 9.93 | -3.62 | 58 |
| 3-Year (Annualized) | 17.53 | 7.95 | -0.68 | 42 |
| 5-Year (Annualized) | 11.62 | 9.81 | -0.04 | 45 |
| 10-Year (Annualized) | 11.08 | 2.79 | 2.24 | 40 |
